834 related articles for article (PubMed ID: 20627492)
21. Current understanding and management of medullary thyroid cancer.
Roy M; Chen H; Sippel RS
Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
[TBL] [Abstract][Full Text] [Related]
22. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
23. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.
Chiefari E; Chiarella R; Crocetti U; Tardio B; Arturi F; Russo D; Trischitta V; Filetti S; Zingrillo M
Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
[TBL] [Abstract][Full Text] [Related]
25. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
Machens A; Lorenz K; Dralle H
Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
[TBL] [Abstract][Full Text] [Related]
26. Current approaches to medullary thyroid carcinoma, sporadic and familial.
Fialkowski EA; Moley JF
J Surg Oncol; 2006 Dec; 94(8):737-47. PubMed ID: 17131404
[TBL] [Abstract][Full Text] [Related]
27. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.
Spinelli C; Di Giacomo M; Costanzo S; Elisei R; Miccoli P
J Pediatr Surg; 2010 Aug; 45(8):1610-6. PubMed ID: 20713208
[TBL] [Abstract][Full Text] [Related]
28. Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
Frank-Raue K; Rondot S; Schulze E; Raue F
Clin Lab; 2007; 53(5-6):273-82. PubMed ID: 17605401
[TBL] [Abstract][Full Text] [Related]
29. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
Quayle FJ; Moley JF
J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378
[TBL] [Abstract][Full Text] [Related]
30. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
Chi DD; Moley JF
Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.
Frank-Raue K; Rondot S; Raue F
Mol Cell Endocrinol; 2010 Jun; 322(1-2):2-7. PubMed ID: 20083156
[TBL] [Abstract][Full Text] [Related]
32. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.
Aydoğan Bİ; Yüksel B; Tuna MM; Navdar Başaran M; Akkurt Kocaeli A; Ertörer ME; Aydın K; Güldiken S; Şimşek Y; Cihan Karaca Z; Yılmaz M; Aktürk M; Anaforoğlu İ; Kebapçı N; Duran C; Taşlıpınar A; Kulaksızoğlu M; Gürsoy A; Dağdelen S; Erdoğan MF
J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):13-20. PubMed ID: 26758973
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines.
Rohmer V; Vidal-Trecan G; Bourdelot A; Niccoli P; Murat A; Wemeau JL; Borson-Chazot F; Schvartz C; Tabarin A; Chabre O; Chabrier G; Caron P; Rodien P; Schlumberger M; Baudin E;
J Clin Endocrinol Metab; 2011 Mar; 96(3):E509-18. PubMed ID: 21190982
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece.
Sarika HL; Papathoma A; Garofalaki M; Vasileiou V; Vlassopoulou B; Anastasiou E; Alevizaki M
Clin Endocrinol (Oxf); 2012 Dec; 77(6):857-62. PubMed ID: 22676047
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population.
Alvandi E; Akrami SM; Chiani M; Hedayati M; Nayer BN; Tehrani MR; Nakhjavani M; Pedram M
Thyroid; 2011 Apr; 21(4):373-82. PubMed ID: 21309721
[TBL] [Abstract][Full Text] [Related]
37. [Prophylactic thyroidectomy in children at risk for medullary thyroid carcinoma].
Torres de Aguirre A; Martínez Carol A; Cabello Laureano R; García Valles C; Gómez Gila A; del Valle Núñez J
Cir Pediatr; 2005 Jul; 18(3):106-8. PubMed ID: 16209369
[TBL] [Abstract][Full Text] [Related]
38. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
Niccoli-Sire P; Murat A; Rohmer V; Gibelin H; Chabrier G; Conte-Devolx B; Visset J; Ronceray J; Jaeck D; Henry JF; Proye C; Carnaille B; Kraimps JL;
Surgery; 2003 Dec; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
[TBL] [Abstract][Full Text] [Related]
39. Medullary Thyroid Carcinoma Associated with Germline RET
Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ
Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361
[TBL] [Abstract][Full Text] [Related]
40. Management of patients with hereditary medullary thyroid carcinoma.
Fitze G
Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]